Ha - i hear you on that one. The SP has made no sense to me - total disconnect between Lalezari coming on board, as if that will have no effect, which is crazy.

I will say that the biotech space in general has been getting killed - and it only accelerated after the collapse of Silicon Valley Bank, one of the biggest biotech lenders - so we're not getting any benefit of the doubt from the sector.

I am assuming we just need to put some points on the board with the protocol, having the second hold lifted, etc., and the SP will respond.